Drug firms seek new strategies

Multinationals shift sales focus as govt tightens measures to check corruption

Pharmaceutical companies, especially multinationals, are looking for new ways to boost sales as China continues to crackdown on corruption.

Following last year's bribery scandal involving British pharmaceutical giant GlaxoSmithKline, multinational pharmaceutical companies in China are watching their conduct in the market. And they know that what they used to do, with sales representatives playing a pivotal role, will no longer be workable in the new market environment.